Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00893126 · ClinicalTrials.gov registry record
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 46
- Enrollment target
NCT00893126: Completed study, sponsored by University of Michigan.
NCT00893126 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00893126 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the prevalence and severity of CAD (coronary artery disease) in patients with and without severe psoriasis, otherwise matched for cardiovascular risk factors.
Interventions
- PROCEDURE CCTA Scan (Coronary CT Angiogram)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2009-11 |
| Est. Completion | 2016-08 |
What the finished NCT00893126 record still lists
NCT00893126 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CCTA Scan (Coronary CT Angiogram) is the first listed.
NCT00893126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00893126 about?
NCT00893126 is a clinical study titled "Premature Coronary Artery Disease (CAD) in Severe Psoriasis". The purpose of this study is to compare the prevalence and severity of CAD (coronary artery disease) in patients with and without severe psoriasis, otherwise matched for cardiovascular risk factors.
What is the current status of trial NCT00893126?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2009-11. Estimated completion is 2016-08.
What interventions are being tested in trial NCT00893126?
The interventions under investigation include: CCTA Scan (Coronary CT Angiogram) (PROCEDURE).
Who is sponsoring clinical trial NCT00893126?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia